|
Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation &
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
November 21, 2008
-
Guidance for Industry: Contents
of a Complete Submission for the
Evaluation of Proprietary Names
[PDF]
November 20, 2008
-
Drugs@FDA Downloadable Data
Files
(updated)
-
Drugs Shortages: Current Drug
Shortages; Leucovorin
-
Drugs Shortages: Current Drug
Shortages; Levoleucovorin (Fusilev)
50 mg single use vials
-
New
and Generic Drug Approvals
-
Accutane
(isotretinoin) Capsules,
Hoffman La-Roche, Inc.,
Labeling Revision
-
Benzphetamine Hydrochloride
Tablets, Impax Labs,
Approval
-
Budesonide
Inhalation Suspension, IVAX
Pharmaceuticals, Inc.,
Approval
-
Emend
(aprepitant) Capsules, Merck
& Co., Inc., Labeling
Revision
-
Ondansetron
Injection, Luitpold
Pharmaceuticals, Inc.,
Approval
-
Pepcid Complete
(calcium carbonate,
famotidine and magnesium
hydroxide) Chewable
Tablets, Merck & Co., Inc.,
Formulation Revision
-
Ranitidine Hydrochloride
Tablets, Glenmark Generics
Inc., USA, Approval
-
Vesicare
(solifenacin succinate)
Tablets, Astellas Pharma US,
Inc., Labeling Revision
November 19, 2008
-
Approved Drug Products with
Therapeutic Equivalence
Evaluations Orange Book
-
Medical, Statistical, and
Clinical Pharmacology Reviews of
Pediatric Studies
(updated)
-
New
and Generic Drug Approvals
-
Alprazolam
Extended-Release Tablets,
Apotex, Inc., Approval
-
Calcitonin-Salmon
Nasal Spray, Apotex, Inc.,
Approval
-
Fluoxetine Hydrochloride
Capsules, Mylan
Pharmaceuticals, Inc.,
Approval
-
Fluoxetine Hydrochloride
Capsules, Sandoz, Inc.,
Approval
-
Midazolam Hydrochloride
Injection, Wockhardt, Ltd.,
Approval
-
Promethazine Hydrochloride
Plain
(promethazine hydrochloride)
Oral Solution, ANI
Pharmaceuticals, Inc.,
Labeling Revision
-
Triglide
(fenofibrate) Tablets,
SkyePharma AG, Labeling
Revision
-
Pharmacometrics at FDA
November 18, 2008
-
CSI
USA Inc. and FDA inform
consumers and healthcare
professionals of a nationwide
recall of all lots of 1 ounce
tubes of 10% Benzoyl Peroxide
Acne Cream.
MedWatch Safety Information
-
Drugs Shortages: Resolved Drug
Shortages; Argatroban Injection
-
E14
Clinical Evaluation of QT/QTc
Interval Prolongation and
Proarrhythmic Potential for Non-Antiarrhythmic
Drugs Questions and Answers [PDF]
-
New
and Generic Drug Approvals
-
Alfuzosin Hydrochloride
Extended-Release Tablets,
Aurobindo Pharma Ltd.,
Tentative Approval
-
Anastrozole
Tablets, Stason
Pharmaceuticals, Inc.,
Tentative Approval
-
Banzel
(rufinamide) Tablets, Eisai
Medical Research, Inc.,
Approval
-
Diclofenac Sodium
Ophthalmic Solution, Apotex,
Approval
-
Qualaquin
(quinine sulfate) Capsules,
AR Holding Co. Inc.,
Labeling Revision
-
Oxycodone and Acetaminophen
Tablets, Coastal
Pharmaceuticals, Approval
-
Venlafaxine Hydrochloride
Extended-Release Capsules,
Mylan Pharmaceuticals Inc.,
Tentative Approval
November 17, 2008
-
Guidance for Industry: Process
Validation: General Principles
and Practices [PDF]
or
[HTML]
-
New
and Generic Drug Approvals
-
Adderall XR
(amphetamine aspartate,
amphetamine sulfate,
dextroamphetamine saccharate
and dextroamphetamine
sulfate) Extended-Release
Capsules, Shire Development,
Inc., Labeling Revision
-
Alprazolam
Extended-Release Tablets,
Apotex Inc., Approval
-
Midazolam Hydrochloride
Injection, Wockhardt Ltd.,
Approval
-
Phenytoin Sodium
Extended-Release Capsules,
Amneal Pharmaceuticals of
NY, Approval
-
Promethazine Hydrochloride
Syrup, ANI Pharmaceuticals,
Inc., Labeling Revision
-
Spiriva
(tiotropium bromide
monohydrate) Inhalation
Powder, Boehringer Ingelheim,
Labeling Revision
-
Vyvanse
(lisdexamfetamine dimesylate)
Capsules, Shire Development,
Inc., Labeling Revision
-
Regulatory Pharmaceutical
Fellowship Opportunity
CDER
Drug Links
|
|
|
November 21, 2008 |
 |
Summary Information
for: Carotid
WALLSTENT Monorail
Endoprosthesis
 |
 |
Consumer Information
on: Carotid
WALLSTENT Monorail
Endoprosthesis -
P050019
 |
 |
Circulatory System
Devices Panel
Advisory Meeting,
November 20, 2008 -
Brief Summary
 |
 |
General and Plastic
Surgery Devices
Panel Advisory
Meeting, November
18-19, 2008 - Brief
Summary
 |
 |
Consumer Information
on: Helios II
Ablation Catheter -
P050029
 |
 |
Summary Information
for: Helios II
Ablation Catheter
 |
|
|
|
November 20, 2008 |
 |
Class I Medical
Device Recall:
Animas Corporation,
Battery Caps Used
with the OneTouch
Ping System, Animas
2020 Insulin Pump,
Animas IR1200
Insulin Pump, and
Animas IR1250
Insulin Pump
 |
|
|
|
November 19, 2008 |
 |
Federal Register:
Global Harmonization
Task Force, Study
Group 1; Proposed
and Final Documents;
Availability
  |
 |
Orthopaedic and
Rehabilitation
Devices Panel
Advisory Meeting,
November 14, 2008 -
Agenda, Roster,
Briefing, Questions,
Summary, Slides
 |
|
|
|
November 18, 2008 |
 |
Federal Register:
Orthopaedic and
Rehabilitation
Devices Panel of the
Medical Devices
Advisory Committee;
Notice of Meeting
  |
|
|
|
November 17, 2008 |
 |
Federal Register:
Agency Information
Collection
Activities; Proposed
Collection; Comment
Request; Guidance;
Compliance With the
Medical Device User
Fee and
Modernization Act of
2002, as Amended:
Prominent and
Conspicuous Mark of
Manufacturers on
Single-Use Devices
  |
|
|
|
Medical Device Links
|
|
This
Week
Rule Changes:
21 CFR Parts
520
-
2
-
601 |
|
Friday,
Nov. 21, 2008 |
NOTICES
Determination:
NUBAIN (Nalbuphine Hydrochloride) Injection, 10 and 20
Milligrams/Milliliter, Was
Not Withdrawn From Sale for
Reasons of Safety or
Effectiveness,
7065370654 [E827714]
[TEXT] [PDF]
Meetings:
Oncologic Drugs Advisory Committee,
7065470655 [E827713]
[TEXT] [PDF]
|
|
Thurs.,
Nov. 20, 2008 |
RULES
Oral Dosage Form New Animal
Drugs:
Amprolium; Correction,
70276 [E827646]
[TEXT] [PDF]
|
|
Wed., Nov.
19, 2008 |
RULES
Use of Ozone-Depleting
Substances; Removal of
Essential-Use Designation
(Epinephrine),
6953269552 [E827436]
[TEXT] [PDF]
NOTICES
Global Harmonization Task
Force, Study Group 1;
Proposed and Final
Documents; Availability,
6966569666 [E827466]
[TEXT] [PDF]
|
|
Tuesday,
Nov. 18, 2008 |
RULES
Exceptions or Alternatives
to Labeling Requirements for
Products Held by the
Strategic National
Stockpile; Technical
Amendment,
6833268333 [E827254]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
6843068431 [E827258]
[TEXT] [PDF]
Industry on Process
Validation, Draft Guidance;
Availability:
General Principles and Practices,
6843168432 [E827321]
[TEXT] [PDF]
Meetings:
Orthopaedic and
Rehabilitation Devices Panel
of the Medical Devices
Advisory Committee,
6843268433 [E827255]
[TEXT] [PDF]
|
|
Monday,
Nov. 17, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
6787367874 [E827178]
[TEXT] [PDF]
Determination of Regulatory
Review Period for Purposes
of Patent Extension;
Somatuline Depot,
6787467875 [E827179]
[TEXT] [PDF]
|
|
|
|
.jpg)


EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|